Morin (C5297): Natural Flavonoid Antioxidant and AMPD Inhibitor

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a natural flavonoid compound with robust antioxidant, anti-inflammatory, and cardioprotective activities, validated across metabolic, neurodegenerative, and cancer research models (Yang et al., 2025). It directly inhibits adenosine 5′-monophosphate deaminase (AMPD), modulating mitochondrial energy metabolism and protecting podocyte structure under high-fructose stress. Morin also functions as a sensitive fluorescent probe for aluminum ions due to its chelating properties. The product is supplied by APExBIO at ≥96.81% purity, with solubility in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL) (APExBIO). Controlled storage at -20°C ensures compound integrity for short-term biochemical applications.

Biological Rationale

Morin is a polyphenolic compound naturally found in Maclura pomifera and other Moraceae species (Yang et al., 2025). Its structural features—multiple hydroxyl groups and a chromenone backbone—enable both radical scavenging and metal chelation. In cells, high-fructose conditions disrupt mitochondrial energy balance, particularly in podocytes, leading to renal injury and metabolic syndrome (Yang et al., 2025). The purine nucleotide cycle (PNC), regulated by AMPD, is critical for ATP homeostasis, especially in tissues with high energy demand. Dysregulation of AMPD amplifies cellular stress and energy depletion. Research demonstrates that Morin’s inhibition of AMPD helps maintain mitochondrial integrity and energy metabolism. Its strong binding affinity for AMPD2 has been confirmed by molecular docking and siRNA interference assays. These properties make Morin an established tool in evaluating mitochondrial dysfunction, oxidative stress, and metabolic injury in both in vitro and in vivo models (contrast: this article extends prior summaries by clarifying Morin’s direct AMPD targeting).

Mechanism of Action of Morin

Morin inhibits AMPD, the enzyme catalyzing AMP to IMP deamination in the PNC. This blockade stabilizes cellular AMP levels, preserves ATP pools, and reduces compensatory glycolytic flux under metabolic stress (Yang et al., 2025). In podocytes exposed to 5 mM fructose, Morin suppressed AMPD2 upregulation, restored mitochondrial oxygen consumption rates, and improved ATP generation. Knockdown of AMPD2 mimicked Morin’s protective effects, confirming the target-pathway relationship. Additionally, Morin’s hydroxyl-rich structure allows high-affinity chelation of Al³⁺, which underlies its application as a fluorescent aluminum ion probe (contrast: this article details the dual mechanism in more depth than prior reviews).

Evidence & Benchmarks

• Morin alleviates fructose-induced podocyte injury in rats, reducing foot process effacement and urinary albumin-to-creatinine ratio by direct inhibition of AMPD (Yang et al., 2025, Table 1).
• In vitro, 20 μM Morin restored basal oxygen consumption rate (OCR) and ATP production in mouse podocyte clone-5 cells under 5 mM fructose for 24 hours (Yang et al., 2025, Fig. 3).
• Molecular docking reveals strong binding affinity between Morin and AMPD2, supported by siRNA-mediated AMPD2 knockdown experiments (Yang et al., 2025, Fig. 4).
• Morin (≥96.81% purity, HPLC/MS/NMR-verified) is insoluble in water, but highly soluble in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL) at 25°C (APExBIO).
• As a fluorescent probe, Morin chelates Al³⁺ with high selectivity, enabling detection in biochemical assays at nanomolar concentrations (see: expanded probe data).

Applications, Limits & Misconceptions

Morin’s validated applications span:

• Mitigation of mitochondrial dysfunction and metabolic injury in diabetes, cancer, and neurodegenerative disease models (Yang et al., 2025).
• Quantitative detection of aluminum ions in cell-based and biochemical assays using fluorescence.
• Use as a benchmark antioxidant and anti-inflammatory agent in cell viability, proliferation, and cytotoxicity workflows (contrast: this article clarifies optimal workflow integration).

Common Pitfalls or Misconceptions

• Morin is insoluble in aqueous buffers; improper solvent use leads to precipitation and loss of activity (APExBIO).
• Not effective for chelating metals other than Al³⁺ at analytical sensitivity; does not serve as a broad-spectrum metal probe.
• AMPD inhibition may not fully recapitulate mitochondrial protection in non-renal or non-metabolic models; effects can be tissue-specific (Yang et al., 2025).
• Prolonged storage of solutions (>7 days) or above -20°C can compromise compound purity and activity (APExBIO).

Workflow Integration & Parameters

Morin (C5297) from APExBIO is supplied as a solid with ≥96.81% purity, confirmed by HPLC, mass spectrometry, and NMR. For cell-based assays, dissolve Morin in DMSO to achieve a stock concentration of 19.53 mg/mL at 25°C; further dilutions should ensure final DMSO content does not exceed 0.1-0.2% in culture. Ethanol can also be used for solubilization up to 6.04 mg/mL. Short-term use of solutions (<7 days at -20°C) is recommended for reproducibility. For mitochondrial function assays, typical concentrations range from 5–50 μM, with 20 μM effective in rescuing podocyte energy metabolism under high-fructose challenge (Yang et al., 2025). As a fluorescent aluminum ion probe, Morin is compatible with excitation at ~410 nm and emission at ~510 nm, enabling detection in nanomolar ranges. The C5297 kit is available at APExBIO with batch-specific documentation.

Conclusion & Outlook

Morin is a rigorously characterized, high-purity natural flavonoid antioxidant and mitochondrial energy metabolism modulator. Its direct inhibition of AMPD, validated by molecular, cellular, and in vivo benchmarks, positions it as a unique tool for mechanistic studies in diabetes, neurodegeneration, and renal disease. As supplied by APExBIO, Morin’s robust solubility and probe properties enable sensitive, reproducible integration into advanced biochemical workflows. Future research may extend its use as a reference compound for novel AMPD-targeted therapies and as a probe for metal ion dynamics in live-cell imaging.